Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

IMPORTANCE: Response-adapted randomized trials have used positron emission tomography–computed tomography to attempt to identify patients with early-stage favorable Hodgkin lymphoma (ESFHL) who could be treated with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) without radiation therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinnix, Chelsea C., Gunther, Jillian R., Fang, Penny, Bankston, Mikaela E, Milgrom, Sarah A., Boyce, David, Lee, Hun Ju, Nair, Ranjit, Steiner, Raphael, Strati, Paolo, Ahmed, Sairah, Iyer, Swaminathan P., Westin, Jason, Parmar, Simrit, Rodriguez, M. Alma, Nastoupil, Loretta, Neelapu, Sattva, Flowers, Christopher, Dabaja, Bouthaina S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525355/
https://www.ncbi.nlm.nih.gov/pubmed/32990738
http://dx.doi.org/10.1001/jamanetworkopen.2020.13935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525355/
https://www.ncbi.nlm.nih.gov/pubmed/32990738
http://dx.doi.org/10.1001/jamanetworkopen.2020.13935

Ejemplares similares